Business

Diagnosis

Diagnosis

We will promote diagnostic projects in the medical, agricultural and biological fields through fast and efficient immunoassays.

ACCEL ELISA®

Stationary Homogeneous Immunoassay Platform Technology with Maximized Speed

Conventional ELISA VS ACCEL ELISA

Classification Conventional VS ACCEL ELISA
Antibody Screening 7.8 ~ 50.0 ng / ml Detection Range 0.39 ~ 25 ng / ml
120min Speed 30min
Biomarker Screening 0.78 ~ 5 ng / ml Detection Range 0.27 ~ 1.6 ng / ml
240min Speed 20min
Cortisol Screening 0.15 ~ 10 ng / ml Detection Range 0.15 ~ 5.0 ng / ml
180min Speed 20min
Disease Screening 1.0 ~ 65 ng / ml Detection Range 0.2 ~ 50 ng / ml
90min Speed 20min
ADVANTAGES OF ACCEL ELISA®
  1. Surface treatment technology

    Minimize non-specific reactions by applying unique surface treatment

  2. Proprietary design of plate and wells

    Increased surface area offers higher sensitivity and improved enzymatic reaction rates.

  3. Proprietary reagent formulation

    Shortening and simplifying the analysis step by applying the homogeneous immunoassay method in which the sample and reaction reagent are simultaneously injected

  4. Conventional ELISA Well

    The unique well design offers a 68% increase in surface area compared to conventional ELISA plates.

  5. ACCEL ELISA® Well

    The unique well design offers a 68% increase in surface area compared to conventional ELISA plates.

Applications
  1. COVID-19
    • Serum Antibody
    • Saliva Antigen 
    • Neutralizing Antibody
  2. Food Safety
    • Aflatoxin M1 Test
    • Aflatoxin B1 Test
    • Zearalenone Test
    • Deoxynivalenol Test
    • Fumonisin Test
    • Ochratoxin Test
    • Streptomycin Test
    • Oxytetracycline Test
  3. Agricultural Crop
    • Citrus greening Disease
    • Cotton blue Disease
  4. Canine Disease
    • Heartworm
    • Measles
    • Coronavirus
    • Enteritis Diagnosis
  5. Human Disease
    • Cortisol Stress Hormone
    • Early Bladder Cancer

Covid-19 diagnosis kit

  • Serum Antibody diagnosis Kit
  • Saliva antigen diagnosis kit
  • Neutralizing Antibody diagnosis Kit
  • Rapid diagnosis Kit (OEM)
Classfication Serum Antibody diagnosis Kit
“ACCEL ELISA® COVID-19
kit” 		Saliva antigen diagnosis kit
“ACCEL ELISA® COVID-19
Saliva Antigen kit” 		Neutralizing Antibody diagnosis Kit
“ACCEL ELISA® COVID-19
Neutralizing Antibody kit”
Purpose Confirmation of antibody production by COVID-19 infection Confirmation of the presence of specific proteins in the COVID-19 Confirmation of Immune Antibodies to COVID-19 Virus
*Large-scale Immune Antibody Investigation After Vaccination
Test Time 30min 2hours 1hour
Sensitivity / Specificity Sensitivity : 94.4%
Specificity : 100%		 Sensitivity : 91.7%
Specificity : 97.1%		 Sensitivity : 100%
Specificity : 99.96%
Sample Blood (serum) Saliva Blood (serum)
Remarks 100% accuracy after 5 days of symptom onset Capable of collecting large-scale mass samples with saliva Post-vaccination monitoring possible
Certification Status European CE certification completed
KFDA approval in progress
Completion of many country certifications		 Export license certification completed
CE certification completed		 Export license certification completed
CE certification completed

Parkinson's disease early diagnosis kit

Parkinson's disease
  • Motor dysfunction due to loss of neurons that secrete dopamine in the brain
  • The second most common neurodegenerative disease after Alzheimer's disease
ADVANTAGES
Biomarker
Sensitivity
94%
Specificity
91%
Goal
Development RUO Product in 2022